3M (MMM) FY2025 10-K Annual Report

Filed: Feb 3, 2026
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR

3M (MMM) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 3, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

3M FY2025 10-K Analysis

Business Overview

  • Core business: Diversified technology company focused on innovation and ethical conduct across multiple industries
  • Strategic divestiture: Separation and distribution of Solventum Corporation completed in March 2024, with multiple transition agreements executed
+3 more insights

Management Discussion & Analysis

  • Revenue $35.4B, declined 4% YoY from $36.9B in prior year
  • Operating margin 18.2% vs 19.7% prior year, decrease driven by increased costs
+3 more insights

Risk Factors

  • Regulatory/legal risk: 2025 PFAS-related New Jersey Settlement litigation and site remediation obligations increasing net costs and impacting operating income
  • Geopolitical/macro risk: EMEA region organic sales declined 1.7% in 2025, with ongoing tariff impacts raising cost of sales
+3 more insights

3M FY2025 Key Financial Metrics
XBRL

Revenue

$24.9B

+1.5% YoY

Net Income

$3.3B

-22.1% YoY

Operating Margin

18.6%

-107bp YoY

Net Margin

13.0%

-395bp YoY

ROE

69.1%

-3950bp YoY

Total Assets

$37.7B

-5.4% YoY

EPS (Diluted)

$6.00

-20.5% YoY

Operating Cash Flow

$2.3B

+26.8% YoY

Source: XBRL data from 3M FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on 3M

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.